Skip to content

Teladoc Health TDOC Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Doximity logo
DoximityDOCS
Omada Health, Inc. Common Stock logo
Omada Health, Inc. Common StockOMDA
ARD
Ardent Health PartnersARDT
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
Humana logo
HumanaHUM
Tenet Healthcare logo
Tenet HealthcareTHC

Other financials

Income statement

See full
Revenue$613.8M-2.5%
Gross profit$416.3M-3.8%
Operating income-$61.8M+48.8%
Net income-$63.8M+31.4%
EPS (diluted)-$0.36+32.1%

Balance sheet

See full
Cash & equivalents$750.7M-37.1%
Total debt$42.2M-92.9%
Total equity$1.3B-6.4%
Total assets$2.8B-18.5%

Cash flow

See full
Operating cash flow$9.5M-40.2%
CapEx$1.7M-39.1%
Free cash flow$7.9M-40.5%

Valuation

See full
Market cap$1.41B-29.7%
Enterprise value$701.31M-66.3%
P/S0.6×-0.2×

Profitability

See full
Gross margin69.3%-1.2pp
Operating margin-8.1%-3.6pp
Net margin-6.8%-3.1pp
FCF margin11.1%-0.2pp

Returns & leverage

See full
Return on equity-12.4%-5.4pp
Debt / equity-0.4×
Current ratio2.8×+1.1×

Where this comes from

Reported directly by Teladoc Health in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Teladoc Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teladoc Health's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teladoc Health's common stock, shares authorized (in shares)?
Teladoc Health (TDOC) reported common stock, shares authorized (in shares) of $300M in Q1 2026.
How has Teladoc Health's common stock, shares authorized (in shares) changed year-over-year?
Teladoc Health's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $300M to $300M.
What is the long-term trend for Teladoc Health's common stock, shares authorized (in shares)?
Over 3 years (2022 to 2025), Teladoc Health's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $300M to $300M.